Opendata, web and dolomites

Tau Seeding SIGNED

Identification and validation of human proteins that control tau seeding in cell-based and in vivo models

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 Tau Seeding project word cloud

Explore the words cloud of the Tau Seeding project. It provides you a very rough idea of what is the project "Tau Seeding" about.

robustly    assay    causal    alzheimer    drug    inhibit    molecular    comprehensively    neurodegenerative    details    models    ultimately    tauopathies    knockdown    lay    functional    slow    understand    misfolding    proteins    therapeutic    relationships    purpose    self    illnesses    indirectly    misfolded    literature    tau    hits    soluble    sensitive    linked    attempted    strategies    modulate    premise    foundation    proteostasis    unravel    post    systematic    disease    fret    seeds    life    interfere    screens    mechanistic    shrna    influence    protein    translationally    pathogenic    disorders    preselected    chemical    stall    delineate    screen    share    cycle    seeding    cell    gene    cellular    progression    genes    500    kinases    modulation    cascade    validation    templates    medium    interactors    elegans    compounds    mechanism    perform    modify    function    microtubule    propagation    hypothesized    aggregates    network    biosensor    neurological    regulators   

Project "Tau Seeding" data sheet

The following table provides information about the project.

Coordinator
MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC) 

Organization address
address: ROBERT ROSSLE STRASSE 10
city: BERLIN
postcode: 13125
website: www.mdc-berlin.de

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Germany [DE]
 Total cost 171˙460 €
 EC max contribution 171˙460 € (100%)
 Programme 1. H2020-EU.1.3.2. (Nurturing excellence by means of cross-border and cross-sector mobility)
 Code Call H2020-MSCA-IF-2016
 Funding Scheme MSCA-IF-EF-ST
 Starting year 2017
 Duration (year-month-day) from 2017-11-01   to  2020-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN IN DER HELMHOLTZ-GEMEINSCHAFT (MDC) DE (BERLIN) coordinator 171˙460.00

Map

 Project objective

The microtubule-associated protein tau is the most commonly misfolded protein in neurodegenerative disorders including Alzheimer’s disease and other related tauopathies. These neurological illnesses are hypothesized to share a common mechanism of disease progression, where pathogenic aggregates or ‘seeds’ of the tau protein function as templates promoting misfolding of functional, soluble tau protein. Under this premise, therapeutic strategies that modulate the seeding cascade, have high potential to interfere with the disease process. I will apply a recently developed highly sensitive and specific FRET-based biosensor cell assay as well as C.elegans to identify proteins that robustly influence tau seeding to understand the self-propagation process, ultimately aiming to stall disease progression. To this purpose, I will perform an shRNA-based knockdown screen of ~500 target genes preselected from literature, with potential to influence tau seeding. These will include known interactors of tau, proteostasis and tau life cycle regulators, and kinases, which modify tau post-translationally. After systematic validation, hits will be comprehensively investigated to unravel the mechanistic details of how modulation of the seeding activity was induced by the relevant gene. In addition, based on the results from the cellular assay, network models will be generated that delineate the causal relationships between identified target genes and tau seeding. This will help to understand, which proteins are able to directly or indirectly affect tau seeding, based on which new drug screens can be established. Moreover, already known drug targets will be attempted to be linked to cellular pathways, which have been identified to be relevant to tau seeding. In the medium term, this study may not only identify novel target genes and molecular pathways but also lay the important foundation to identify chemical compounds that slow or inhibit tau seeding.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "TAU SEEDING" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "TAU SEEDING" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.3.2.)

5G-ACE (2019)

Beyond 5G: 3D Network Modelling for THz-based Ultra-Fast Small Cells

Read More  

MemoryAggregates (2020)

Mechanism of Whi3 Aggregation and its Age-dependent Malfunction

Read More  

CODer (2020)

The molecular basis and genetic control of local gene co-expression and its impact in human disease

Read More